Aquatic Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Aquatic Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,895	Closed	-$2.72M	–	1253
2026 Q1	$2.72M	Buy	+11,895	New	+$2.67M	0.08%	307
2025 Q4	–	Sell	-10,854	Closed	-$2.16M	–	1395
2025 Q3	$2.16M	Buy	10,854 +8,437	+349%	+$1.57M	0.04%	467
2025 Q2	$417K	Sell	2,417 -28,093	-92%	-$4.58M	0.01%	871
2025 Q1	$4.76M	Buy	30,510 +28,836	+1,723%	+$4.12M	0.12%	222
2024 Q4	$230K	Buy	+1,674	New	+$220K	0.01%	898
2024 Q2	–	Sell	-4,300	Closed	-$650K	–	1215
2024 Q1	$650K	Buy	+4,300	New	+$614K	0.02%	490
2023 Q4	–	Sell	-2,800	Closed	-$262K	–	1315
2023 Q3	$262K	Sell	2,800 -100	-3%	-$9.36K	0.01%	622
2023 Q2	$259K	Buy	2,900 +400	+16%	+$34.8K	0.01%	601
2023 Q1	$268K	Buy	+2,500	New	+$286K	0.02%	529

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aquatic Capital Management's ASND Position: Q2 2026 in Review

Aquatic Capital Management sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 11,895 shares — an estimated $2.72M sold.

Aquatic Capital Management first reported a position in ASND in Q1 2023 and held it in 9 quarters. The position peaked at $4.76M in Q1 2025. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Aquatic Capital Management reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
Aquatic Capital Management sold 11,895 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.72M.
Aquatic Capital Management first reported a position in Ascendis Pharma A/S in Q1 2023 and held it in 9 quarters.
Aquatic Capital Management's Ascendis Pharma A/S position peaked at $4.76M in Q1 2025.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.